Infants with Placebo/no Seizures in neonatal Chaudhari64 2012 Allopurinol 3 114 58 RR Fixed 0.93 (0.75, 1.16) treatment period encephalopathy Agarwal ADDIN EN.CITE Patients with elevated SUA or Placebo/no -3.33 (-5.25, 2013 Allopurinol SBP (mmHg) 10 738 NA MD Random NO ADDIN kidney treatment EN.CITE dysfunction Bose ADDIN 65 EN.CITE (discordance in Patients with statistical CKD or Placebo/no -2.70 (-7.30, significance) 2014 Allopurinol SBP (mmHg) 5 309 NA MD Random decreased kidney treatment 1.90) function Agarwal ADDIN EN.CITE Patients with elevated SUA or Placebo/no -1.29 (-2.48, 2013 Allopurinol DBP (mmHg) 10 738 NA MD Random NO ADDIN kidney treatment EN.CITE dysfunction Bose ADDIN 65 EN.CITE (discordance in Patients with statistical CKD or Placebo/no -1.90 (-4.90, significance) 2014 Allopurinol DBP (mmHg) 5 309 NA MD Random decreased kidney treatment 1.20) function
Chaudhari64 2012 Infants with encephalopathy Allopurinol Placebo/no treatment Seizures in neonatal period 3 114 58 RR Fixed 0.93 (0.75, 1.16) Agarwal ADDIN EN.CITE 2013 Patients with elevated SUA or kidney dysfunction Allopurinol Placebo/no treatment SBP (mmHg) 10 738 NA MD Random -3.33 (-5.25, NO ADDIN EN.CITE 65 (discordance in statistical significance) Bose ADDIN EN.CITE 2014 Patients with CKD or decreased kidney function Allopurinol Placebo/no treatment SBP (mmHg) 5 309 NA MD Random -2.70 (-7.30, 1.90) Agarwal ADDIN EN.CITE 2013 Patients with elevated SUA or kidney dysfunction Allopurinol Placebo/no treatment DBP (mmHg) 10 738 NA MD Random -1.29 (-2.48, NO ADDIN EN.CITE 65 (discordance in statistical significance) Bose ADDIN EN.CITE 2014 Patients with CKD or decreased kidney function Allopurinol Placebo/no treatment DBP (mmHg) 5 309 NA MD Random -1.90 (-4.90, 1.20)
Supplementary%20material_v7%20-%20Final-2.docx